Daxor Cash on Hand 2010-2011 | DXR

Daxor cash on hand from 2010 to 2011. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Daxor Annual Cash on Hand
(Millions of US $)
2011 $56
2010 $54
2009 $54
Daxor Quarterly Cash on Hand
(Millions of US $)
2011-12-31 $56
2011-09-30 $52
2011-06-30 $54
2011-03-31 $53
2010-12-31 $54
2010-09-30 $58
2010-06-30 $49
2010-03-31 $76
2009-12-31 $54
2009-09-30 $70
2009-06-30 $70
2009-03-31 $58
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.775B 18.50
Encompass Health (EHC) United States $11.124B 23.58
DaVita (DVA) United States $10.825B 15.22
Elanco Animal Health (ELAN) United States $7.430B 15.91
Chemed (CHE) United States $6.692B 21.03
Option Care Health (OPCH) United States $4.903B 21.85
RadNet (RDNT) United States $4.415B 280.19
Amedisys (AMED) United States $3.199B 21.52
Addus HomeCare (ADUS) United States $2.018B 22.16
LifeStance Health (LFST) United States $1.719B 0.00
Astrana Health (ASTH) United States $1.384B 34.29
U.S Physical Therapy (USPH) United States $1.139B 29.39
Pennant (PNTG) United States $0.824B 30.27
Aveanna Healthcare Holdings (AVAH) United States $0.784B 44.67
Atai Life Sciences (ATAI) Germany $0.559B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.040B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00